Position in NVS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,917,312
+$40,931 QoQ
Shares Held
12,234
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#444
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHYSICIANS FINANCIAL SERVICES, INC. holds $25,900,793 across 8 Drug Manufacturers - General names. NVS ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,192 | $6,227,441 | |
| 2 | AMGN |
Amgen Inc
|
16,942 | $6,135,037 | |
| 3 | JNJ |
Johnson & Johnson
|
23,841 | $6,054,898 | |
| 4 | ABBV |
AbbVie Inc.
|
12,050 | $3,032,262 | |
| 5 | NVS |
Novartis AG
This page
|
12,234 | $1,917,312 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,970 | $1,409,645 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,692 | $788,933 | |
| 8 | PFE |
Pfizer Inc
|
13,923 | $335,265 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,917,312 | 12,234 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,876,381 | 12,284 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,693,595 | 12,284 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,594,536 | 12,434 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,528,840 | 12,634 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,430,734 | 12,834 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,271,647 | 13,068 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,531,836 | 13,318 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,441,787 | 13,543 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,310,014 | 13,543 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,407,824 | 13,943 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,434,494 | 14,083 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,421,115 | 14,083 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,286,436 | 13,983 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,277,609 | 14,083 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,070,448 | 14,083 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,198,888 | 14,183 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $1,246,752 | 14,208 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,271,201 | 14,533 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,231,443 | 15,058 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,401,263 | 15,358 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,362,807 | 15,943 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $1,268,478 | 13,433 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,192,221 | 13,710 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,138,214 | 13,032 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,065,996 | 12,929 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||